Artal Group S.A. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 141 filers reported holding TG THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,691
-99.9%
511,389
-36.1%
0.46%
+43.3%
Q1 2022$7,608,000
-49.9%
800,0000.0%0.32%
-22.6%
Q4 2021$15,200,000
-42.9%
800,0000.0%0.41%
-30.9%
Q3 2021$26,624,000
-14.2%
800,0000.0%0.60%
-5.4%
Q2 2021$31,032,000
-57.1%
800,000
-46.7%
0.63%
-50.7%
Q1 2021$72,300,000
-7.3%
1,500,0000.0%1.28%
-23.8%
Q4 2020$78,030,000
+94.4%
1,500,0000.0%1.68%
+72.0%
Q3 2020$40,140,000
+17.7%
1,500,000
-14.3%
0.97%
+2.1%
Q2 2020$34,090,000
+246.4%
1,750,000
+75.0%
0.95%
+129.3%
Q1 2020$9,840,000
+36.4%
1,000,000
+53.8%
0.42%
+49.1%
Q4 2019$7,215,000
+42.8%
650,000
-27.8%
0.28%
+37.4%
Q3 2019$5,054,000
-35.1%
900,0000.0%0.20%
-35.6%
Q2 2019$7,785,000
+21.0%
900,000
+12.5%
0.32%
+19.8%
Q1 2019$6,432,000
+292.2%
800,000
+100.0%
0.26%
+331.1%
Q4 2018$1,640,000
-26.8%
400,0000.0%0.06%
+5.2%
Q3 2018$2,240,000
-57.4%
400,0000.0%0.06%
-48.2%
Q2 2018$5,260,000
+48.2%
400,000
+60.0%
0.11%
+154.5%
Q1 2018$3,550,000
+8.2%
250,000
-37.5%
0.04%
-10.2%
Q4 2017$3,280,000
-30.8%
400,0000.0%0.05%
-40.2%
Q3 2017$4,740,000
-5.7%
400,000
-20.0%
0.08%
-6.8%
Q2 2017$5,025,000500,0000.09%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders